<DOC>
	<DOCNO>NCT01205893</DOCNO>
	<brief_summary>The purpose study determine Reducer safe effective treating symptom refractory angina patient suffer refractory angina demonstrate reversible ischemia .</brief_summary>
	<brief_title>Coronary Sinus Reducer Treatment Refractory Angina - COSIRA</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<criteria>1 . Patient old 18 year age 2 . Symptomatic CAD chronic refractory angina pectoris classify Canadian Cardiovascular Society grade III IV despite attempt optimal medical therapy thirty day prior screen 3 . Patient limit treatment option revascularization coronary artery bypass graft percutaneous coronary intervention 4 . Evidence reversible ischemia attributable leave coronary arterial system Dobutamine Echo 5 . Left ventricular ejection fraction great 25 % 6 . Male nonpregnant female ( NB : Females child bear potential must negative pregnancy test ) 7 . Patient understands nature procedure provide write informed consent prior enrollment 8 . Patient willing comply specify followup evaluation contact telephone 1 . Recent ( within three month ) acute coronary syndrome 2 . Recent ( within six month ) successful PCI CABG 3 . Unstable angina ( recent onset angina , crescendo angina , rest angina ECG change ) thirty day prior screen 4 . Decompensated congestive heart failure ( CHF ) hospitalization due CHF three month prior screen 5 . Life threaten rhythm disorder rhythm disorder would require placement internal defibrillator pacemaker 6 . Severe chronic obstructive pulmonary disease ( COPD ) indicate forced expiratory volume one second le 55 % predict value 7 . Patient undergo exercise tolerance test ( bicycle ) reason refractory angina 8 . Severe valvular heart disease 9 . Patient pacemaker defibrillator electrode right atrium , right ventricle , coronary sinus 10 . Patient undergone tricuspid valve replacement repair 11 . Chronic renal failure ( serum creatinine &gt; 2 mg/dL ) , include patient chronic hemodialysis 12 . Moribund patient , patient comorbidities limit life expectancy le one year 13 . Contraindication require study medication adequately control premedication 14 . Known allergy stainless steel nickel 15 . Contraindication MRI perform ( NB : Cardiac MRI subset patient ) 16 . Currently enrol another investigational device drug trial complete primary endpoint clinically interfere current study endpoint 17 . Mean right atrial pressure high equal 15 mmHg 18 . Patient anomalous abnormal CS demonstrate angiogram . Abnormality define : Abnormal CS anatomy ( e.g. , tortuosity , aberrant branch , persistent leave SVC ) and/or ; CS diameter site plan reducer implantation le 9.5 mm great 13 mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>